✦ LIBER ✦

Efficacy and safety of a new HMG-CoA reductase inhibitor, NK-104, in patients with hypertriglyceridemia — Randomized double-blind, cross-over placebo controlled study

✍ Scribed by J Sasaki; Y Ikeda; K Yamamoto; M Ageta; K Arakawa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-Blind, Randomized, Placebo-Contro

✍ Henry Krum; Emma Ashton; Christopher Reid; Victor Kalff; Jim Rogers; John Amaren 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Dose-dependent Safety and Efficacy of Zo

✍ Martin J. Brodie; Roderick Duncan; Herve Vespignani; Andras Solyom; Valeriy Bite 📂 Article 📅 2005 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 170 KB

A double-blind controlled trial on the e

✍ Terry A. Jacobson; Margaret Chin; Gregg Fromell; Louis F. Amorosa; Leonard A. Jo 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Efficacy and Safety of Darusentan in Pat

✍ Henry R. Black; George L. Bakris; Michael A. Weber; Robert Weiss; Mahfouz El Sha 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 246 KB

Efficacy and safety of pramipexole in Ja

✍ Yuichi Inoue; Koichi Hirata; Kenji Kuroda; Masahiko Fujita; Tetsuo Shimizu; Naru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Efficacy and safety of canagliflozin in

✍ Inagaki, N.; Kondo, K.; Yoshinari, T.; Maruyama, N.; Susuta, Y.; Kuki, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB